Breaking News Instant updates and real-time market news.

ANW

Aegean Marine

$4.25

-0.1 (-2.30%)

, TTD

Trade Desk

$50.06

-3.93 (-7.28%)

17:38
08/10/17
08/10
17:38
08/10/17
17:38

On The Fly: After Hours Movers

UP AFTER EARNINGS: Paylocity (PCTY), up 6.2%... Trade Desk (TTD), up 5.9%... Aegean Marine (ANW), up 4.7%... Camping World (CWH), up 4.5%... Noodles & Company (NDLS), up 3.9%... Nordstrom (JWN), up 3.2%. ALSO HIGHER: Achieve Life Sciences (ACHV), up 22.9% after the FDA accepted its IND application for Cystisine as a smoking cessation treatment... Electronics for Imaging (EFII), up 4.4% after it disclosed in a regulatory filing that it is in the process of evaluating its internal controls and assessing the timing of recognition of revenue. DOWN AFTER EARNINGS: Snap (SNAP), down 17.6%... NVIDIA (NVDA), down 6.8%. ALSO LOWER: EnteroMedics (ETRM), down 9.4% after it announced an offering of convertible preferred stock and warrants... Norwegian Cruise Line (NCLH), down 3.3% after it filed to sell 15M ordinary shares for holders.

ANW

Aegean Marine

$4.25

-0.1 (-2.30%)

TTD

Trade Desk

$50.06

-3.93 (-7.28%)

NDLS

Noodles & Company

$3.90

-0.1 (-2.50%)

CWH

Camping World

$31.47

-0.95 (-2.93%)

PCTY

Paylocity

$43.35

-1.33 (-2.98%)

JWN

Nordstrom

$44.87

-2.01 (-4.29%)

ACHV

Achieve Life Sciences

$2.97

-0.5 (-14.41%)

EFII

Electronics for Imaging

$29.40

-0.88 (-2.91%)

SNAP

Snap

$13.77

0.21 (1.55%)

NVDA

Nvidia

$164.74

-7.37 (-4.28%)

ETRM

EnteroMedics

$3.31

0.05 (1.53%)

NCLH

Norwegian Cruise Line

$57.07

-1.29 (-2.21%)

  • 10

    Aug

  • 10

    Aug

  • 10

    Aug

  • 10

    Aug

  • 10

    Aug

  • 10

    Aug

  • 10

    Aug

  • 10

    Aug

  • 10

    Aug

  • 11

    Aug

  • 15

    Aug

  • 16

    Aug

  • 16

    Aug

  • 18

    Aug

  • 21

    Aug

  • 23

    Aug

  • 29

    Aug

  • 30

    Aug

  • 13

    Sep

  • 26

    Sep

  • 11

    Aug

ANW Aegean Marine
$4.25

-0.1 (-2.30%)

05/24/17
CLKS
05/24/17
DOWNGRADE
CLKS
Neutral
Aegean Marine downgraded to Neutral from Buy at Clarksons Platou
06/01/17
STFL
06/01/17
UPGRADE
STFL
Buy
Aegean Marine upgraded to Buy from Hold at Stifel
06/02/17
STFL
06/02/17
UPGRADE
STFL
Buy
Aegean Marine upgraded on multiple catalysts at Stifel
As noted earlier, Stifel upgraded Aegean Marine to Buy from Hold. As reasons for the upgrade, analyst Benjamin Nolan cited valuation, upcoming changes in the company's management, and its ability to monetize assets. Target $9.
07/21/17
STFL
07/21/17
NO CHANGE
STFL
Aegean Marine new president positive, says Stifel
Stifel analyst Benjamin Noalan says that the appointment of Jonathan Mcilroy as Aegean's new president "represents a solid step forward" for the company. He notes that Mcilroy joined the company only 18 months ago "and has successfully implemented significant volume growth and geographic expansion" in his position as head of retail sales. The analyst keeps a Buy rating on the stock.
TTD Trade Desk
$50.06

-3.93 (-7.28%)

05/12/17
CANT
05/12/17
UPGRADE
Target $55
CANT
Overweight
Trade Desk upgraded to Overweight from Neutral at Cantor
Cantor Fitzgerald analyst Kip Paulson upgraded The Trade Desk to Overweight and raised his price target for the shares to $55 from $40 following the company's better than expected Q1 results. Jefferies this morning raised its price target for the shares to $57.
05/12/17
JEFF
05/12/17
NO CHANGE
Target $57
JEFF
Buy
Trade Desk price target raised to $57 from $41 at Jefferies
Jefferies analyst Brian Fitzgerald raised his price target for The Trade Desk to $57 saying the company is "firing on all cylinders" following its third straight beat quarter. The stock remains a top small pick at Jefferies. Trade Desk continues to outgrow the industry and is capturing incremental ad dollars, Fitzgerald tells investors in a post-earnings research note. He reiterates a Buy rating on the shares.
05/12/17
RBCM
05/12/17
NO CHANGE
RBCM
Trade Desk price target raised to $56 from $45 at RBC Capital
RBC Capital analyst Mark Mahaney raised his price target on Trade Desk after the company delivered beat and raise results. The analyst says that the results were "very strong," and he remains upbeat on the company's fundamentals. Mahaney keeps an Outperform rating on the stock.
05/12/17
NEED
05/12/17
NO CHANGE
Target $56
NEED
Buy
Trade Desk price target raised to $56 from $48 at Needham
Needham analyst Kerry Rice raised his price for Trade Desk to $56 from $48 after posting another blowout in Q1 with new customer wins and mobile as the primary drivers. For the balance of the year, the analyst expects mobile, video, and international expansion to be the primary drivers of incremental revenue with programmatic TV to follow. He reiterates a Buy rating on the shares.
NDLS Noodles & Company
$3.90

-0.1 (-2.50%)

11/25/16
PIPR
11/25/16
NO CHANGE
PIPR
Piper thinks blocking of Overtime Rule came too late
An Obama-appointed judge in Texas surprisingly blocked the Overtime Rule set to take effect on December 1, Piper Jaffray analysts in the Hardlines Retail & Specialty Products space tell investors in a research note. The analysts say that regardless of whether the injunction is upheld, their research suggests that the ruling comes too late for larger companies to pull back on the planned Overtime Rule change. Payroll and IT systems are likely set to adjust this coming Sunday, they point out. Piper's analysts expect the expense headwinds from the OT rule change for retailers/restaurants to remain in place. The retailers they believe that are most impacted from the rule are Dollar General (DG), Dollar Tree (DLTR), Regis (RGS) and Sally Beauty (SBH). The restaurants they believe are most impacted are Bojangles (BOJA), Starbucks (SBUX), Sonic (SONC), Noodles & Company (NDLS), Potbelly (PBPB), Del Taco (TACO) and Zoe's Kitchen (ZOES).
12/02/16
12/02/16
NO CHANGE

With Chipotle in activist's sights, Piper reviews restaurant activism success
Noting that activist investors have recently disclosed their involvement with both Chipotle (CMG) and Fiesta Restaurant Group (FRGI), Piper Jaffray analyst Nicole Miller Regan took a look back at 149 activist campaigns that occurred in the restaurant industry from 1997 to now and found that 70% of the campaigns are followed by positive returns in the year following a campaign announcement. Of note, two-thirds of those campaigns are followed by returns of more than 20%, said Regan, who added that she expects M&A to become more prevalent in the restaurant sector. Some smaller names she offers for investors to consider in this context include Bravo Brio (BBRG), Ignite Restaurant (IRG), Potbelly (PBPB), BJ's Restaurants (BJRI) and Noodles & Company(NDLS).
01/06/17
UBSW
01/06/17
DOWNGRADE
Target $4
UBSW
Sell
Noodles & Company downgraded to Sell from Neutral at UBS
UBS analyst Dennis Geiger downgraded Noodles & Company to Sell saying the company's turnaround will take time. Visibility into a return to sustainable positive comp growth remains limited, Geiger tells investors in a research note. He lowered his price target for the shares to $4 from $7.
CWH Camping World
$31.47

-0.95 (-2.93%)

07/13/17
JPMS
07/13/17
UPGRADE
Target $38
JPMS
Overweight
Camping World upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Ryan Brinkman upgraded Camping World to Overweight and raised his price target for the shares to $38 from $37. The recreational vehicle industry backdrop is stronger than expected with shipments continuing to rise to new all-time highs, Brinkman tells investors in a research note. He sees potential upside to consensus estimates.
06/21/17
06/21/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Camping World (CWH) initiated with an Outperform at BMO Capital. 2. LendingTree (TREE) initiated with an Outperform at William Blair. 3. DST Systems (DST) initiated with a Buy at DA Davidson. 4. Obalon Therapeutics (OBLN) initiated with an Underperform at Northland. 5. First Defiance Financial (FDEF) initiated with a Hold at Sandler ONeill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/21/17
BMOC
06/21/17
INITIATION
BMOC
Outperform
Camping World initiated at BMO Capital
As noted earlier, BMO Capital started coverage of Camping World Holdings with a $36 price target and an Outperform rating. Analyst Gerrick Johnson thinks the company will benefit from strong RV growth, share gains, and acquisitions, enabling its earnings and EBITDA to beat expectations.
06/21/17
BMOC
06/21/17
INITIATION
Target $36
BMOC
Outperform
Camping World initiated with an Outperform at BMO Capital
BMO Capital initiated Camping World with an Outperform and a $36 price target.
PCTY Paylocity
$43.35

-1.33 (-2.98%)

05/05/17
NEED
05/05/17
NO CHANGE
Target $46
NEED
Buy
Paylocity price target raised to $46 from $40 at Needham
Needham analyst Scott Berg raised his price target for Paylocity to $46 from $40 after the company reported "another strong" quarter. The analyst reiterates a Buy rating on the shares.
05/11/17
WELS
05/11/17
INITIATION
Target $44
WELS
Market Perform
Paylocity initiated with a Market Perform at Wells Fargo
Wells Fargo analyst initiated Paylocity with a Market Perform and a $44 price target citing profitability metrics are below other HCM peers.
05/25/17
NEED
05/25/17
NO CHANGE
Target $52
NEED
Buy
Paylocity price target raised to $52 from $46 at Needham
Needham analyst Scott Berg raised his price target for Paylocity to $52 after spending time with management. The analyst left the meetings "more confident that current demand trends remain strong." He upped his FY18 estimates and keeps a Buy rating on Paylocity.
06/26/17
RHCO
06/26/17
INITIATION
Target $45
RHCO
Hold
Paylocity initiated with a Hold at SunTrust
SunTrust analyst Terry Tillman initiated Paylocity with a Hold and a $45 price target due to valuation and potential ACA headwinds.
JWN Nordstrom
$44.87

-2.01 (-4.29%)

06/14/17
CLVD
06/14/17
NO CHANGE
CLVD
Nordstrom Q2 comps likely trending below consensus at Cleveland Research
07/14/17
JPMS
07/14/17
NO CHANGE
JPMS
Underweight
JPMorgan keeps Underweight on Nordstrom after management meetings
JPMorgan analyst Matthew Boss keeps an Underweight rating on Nordstrom (JWN) after meeting management at the company's headquarters. Management would not comment on their evaluation of strategic alternatives and the meeting was reshuffled to exclude members of the Nordstrom family while incoming CFO Anne Bramman attended but did not actively participate, Boss tells investors in a research note. The analyst views the company's EBITDA roadmap as "increasingly uncertain" with a greater emphasis on fashion to differentiate mix versus Amazon.com (AMZN) and rising costs of customer acquisition. He believes the retailer's fundamental multi-year risk profile is elevated.
06/21/17
GDHS
06/21/17
NO CHANGE
GDHS
Nike-Amazon pact yet another department store headwind, says Gordon Haskett
Gordon Haskett analyst noted the reports of Nike (NKE) nearing a deal to sell directly on Amazon (AMZN), which he said wouldn't impact trends overnight but would represent another headwind for department stores, particularly J.C. Penney (JCP) and Kohl's (KSS), where the brand has a larger penetration than at Macy's (M) and Nordstrom (JWN). He keeps an Accumulate rating on Nordstrom, a Hold rating on Macy's and Reduce rating on both J.C. Penney and Kohl's.
06/09/17
06/09/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Snap (SNAP) downgraded to Neutral from Buy at Citi with analyst Mark May saying a slower than expected roll-out of new platforms and channels like self-serve is slowing down the pace of monetization growth. 2. Domino's Pizza (DPZ) downgraded to Neutral from Buy at Longbow with analyst Alton Stump saying his checks indicate second quarter domestic franchised comparables are up 6.25%-6.75%, versus consensus of 7.4%, and recommends investors take a pause on putting new money to work given recent share strength. 3. Nordstrom (JWN) downgraded to Neutral from Buy at Guggenheim with analyst Michael Binetti saying he does not see much further upside potential, even in a leveraged buyout scenario. The analyst believes a going private buyer could only pay $46 per share to generate a 10% internal rate of return. 4. Cantel Medical (CMD) downgraded to Hold from Buy at Benchmark with analyst Raymond Myers saying that he is increasingly concerned that its comparisons become tougher in the next two quarters. 5. Endo (ENDP) downgraded to Hold following Opana ER removal from market at Stifel with analyst Annabel Samimy saying Endo's recovery "just got harder" following the FDA's request for the company to voluntarily remove Opana ER from the market. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ACHV Achieve Life Sciences
$2.97

-0.5 (-14.41%)

EFII Electronics for Imaging
$29.40

-0.88 (-2.91%)

08/04/17
SIDC
08/04/17
DOWNGRADE
SIDC
Neutral
Electronics for Imaging downgraded to Neutral from Buy at Sidoti
08/04/17
LOOP
08/04/17
NO CHANGE
LOOP
Buy
Loop says Electronics for Imaging impact from restatements 'sounds' minimal
Loop Capital analyst Ananda Baruah noted that Electronics for Imaging postponed the report of its June quarter EPS call to complete an assessment into the timing of revenue recognition, which is "not great news." However, the company said the impact to fundamentals over the aggregate periods of restatement is not material, making it "sound" like the fundamental view of the company remains intact, said Baruah, who has a Buy rating on EFI shares.
08/04/17
08/04/17
DOWNGRADE
Target $28

Underweight
Electronics for Imaging downgraded on accounting uncertainty at Morgan Stanley
As previously reported, Morgan Stanley downgraded Electronics for Imaging to Underweight from Equal Weight and cut its price target to $28 from $42. Analyst Katy Huberty said the accounting investigation creates months of uncertainty and believes downward earnings revisions are likely.
08/04/17
CRSS
08/04/17
DOWNGRADE
CRSS
Hold
Electronics for Imaging downgraded to Hold from Buy at Cross Research
SNAP Snap
$13.77

0.21 (1.55%)

08/10/17
JPMS
08/10/17
NO CHANGE
Target $18
JPMS
Neutral
JPMorgan expects in-line to below results tonight from Snap
Snap after today's close is likely to report in-line to below consensus results, JPMorgan analyst Doug Anmuth tells investors in a pre-earnings research note. He believes Q2 Street expectations are close to his estimates of $188M in revenue and 8M daily active user net adds. Even though consensus estimates have moved lower, Q3 revenue expectations still assume 46% quarter-over-quarter growth, Anmuth writes. He believes this may still be too high, even with the first full quarter of self-serve Snap ads. The analyst keeps a Neutral rating on Snap with an $18 price target.
07/31/17
OTRG
07/31/17
DOWNGRADE
OTRG
Mixed
Snap downgraded to Mixed from Positive at OTR Global
08/07/17
DBAB
08/07/17
NO CHANGE
Target $20
DBAB
Buy
Snap shares should rebound in second half of year, says Deutsche Bank
Snap shares offer a "compelling" risk/reward profile at current levels, Deutsche Bank analyst Lloyd Walmsley tells investors in a research note titled "Remember, It's a 2H Story." The analyst sees "innovation thriving" at Snap across the app, advertising product and ad technology. Intra quarter ad checks have started to pick up with industry contacts noting brand advertisers are increasingly of the view that Snap offers compelling view rates and view-to-completion rates, Walmsley writes. He expects continued product innovation to drive growth in daily active users and engagement over time. Snap shares should rebound in the second half of 2017 as it's "inflection comes into focus," Walmsley argues. He lowered his price target for the shares to $20 from $23 and keeps a Buy rating on the name. The analyst points out that his new lowered price target still reflects 51% upside from current share levels. Snap closed Friday up 60c to $13.52.
08/10/17
SBSH
08/10/17
NO CHANGE
SBSH
Neutral
Citi prefers Snap shares over Twitter
Citi analyst Mark May says that while neither are Buy rated, he prefers shares of Snap (SNAP) over Twitter (TWTR). Snap's active user base in the U.S. is more than double Twitter's, which highlights the "greater long-term opportunity for value creation," May tells investors in a research note ahead of Snap's Q2 results today. He adds that Snap is growing its active user base "significantly faster" than Twitter's and that Snap's average user is "significantly more engaged" on the platform. May has a Neutral rating on Snap and a Sell rating on Twitter.
NVDA Nvidia
$164.74

-7.37 (-4.28%)

08/09/17
JPMS
08/09/17
NO CHANGE
JPMS
Neutral
Nvidia expectations high, buy option protection, says JPMorgan derivatives team
JPMorgan equity derivatives strategist Shawn Quigg recommends Nvidia shareholders "add protection" ahead of the company's earnings report tomorrow with expectations appearing to be high. He suggests buying August 11 weekly 165 puts. JPMorgan equity analyst Harlan Sur, who covers the stock for the firm, has a Neutral rating and $122 price target on Nvidia shares.
07/28/17
MACQ
07/28/17
NO CHANGE
Target $40
MACQ
Outperform
Intel long-term growth sustainable, says Macquarie
Macquarie analyst Srini Pajjuri said Intel (INTC) reported a solid quarter and raised its FY17 outlook. The analyst believes PC inventory risk is largely in guidance and DCG growth was better, and thinks the best is yet to come for Purley. The analyst believes 8-10% growth is sustainable longer term as any gains by AMD (AMD) should be limited to the low end and Purley's AI/ML workload performance should sustain Intel's lead in inferencing against Nvidia (NVDA). Pajjuri rates Intel an Outperform with a $40 price target.
07/24/17
ADAM
07/24/17
NO CHANGE
Target $180
ADAM
Buy
Nvidia price target raised to $180 from $155 at Canaccord
Canaccord analyst Matthew Ramsay raised his price target on Nvidia to $180 from $155 as his overall bullish thesis on GPU computing continues to accelerate. Ramsay, who said Nvidia's emergence as a platform computing company is now cemented, reiterated his Buy rating on the shares.
07/18/17
BMOC
07/18/17
NO CHANGE
BMOC
AMD outlook mixed, says BMO Capital
BMO Capital analyst Ambrish Srivastava says he is "a bit cautious" on AMD (AMD) heading into its results as he believes that crypto mining demand and profitability "could collapse." However, the analyst remains upbeat on AMDs longer term outlook, as he thinks that it can deliver "consistent execution in its emerging product areas" and gain share from Intel (INTC) and Nvidia (NVDA). He keeps an Outperform rating on AMD.
ETRM EnteroMedics
$3.31

0.05 (1.53%)

05/03/17
LTCO
05/03/17
INITIATION
Target $11
LTCO
Buy
EnteroMedics initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Jeffrey Cohen started EnteroMedics with a Buy rating and $11 price target.
NCLH Norwegian Cruise Line
$57.07

-1.29 (-2.21%)

08/04/17
STFL
08/04/17
NO CHANGE
STFL
Norwegian Cruise Line should deliver beat and raise results, says Stifel
Stifel analyst Steven Wieczynski says that the results and comments of Royal Caribbean (RCL) and Carnival (CCL) indicate that Norwegian Cruise Line (NCL) will report beat and raise Q2 results. The analyst expects Norwegian, like Royal Caribbean and Carnival, to benefit from higher prices. He also expects Norwegian to be boosted by a reduction of "operational headwinds" which should enable its yield to rise more than that of its peers in 2018. The analyst keeps a $60 price target and a Buy rating on Norwegian.
08/02/17
GSCO
08/02/17
UPGRADE
Target $115
GSCO
Neutral
Royal Caribbean upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Stephen Grambling upgraded Royal Caribbean (RCL) to Neutral citing "strong" leisure trends following the company's better than expected Q2 results. The analyst says his sell thesis has failed to materialize. He raised his price target for the shares to $115 from $99. Grambling also raised his price target for Neutral-rated Carnival (CCL) to $68 from $60 and for Neutral-rated Norwegian Cruise Line (NCLH) to $60 from $55.
07/24/17
BOFA
07/24/17
INITIATION
Target $65
BOFA
Buy
Norwegian Cruise Line initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Andrew Didora initiated Norwegian Cruise Line with a Buy and a $65 price target saying shares trade at a discount to peers despite solid net yield trends, a newer fleet, and high margins.
05/26/17
WEDB
05/26/17
UPGRADE
WEDB
Outperform
Norwegian Cruise Line upgraded to Outperform from Neutral at Wedbush

TODAY'S FREE FLY STORIES

KSU

Kansas City Southern

$105.80

-0.07 (-0.07%)

17:45
08/18/17
08/18
17:45
08/18/17
17:45
Hot Stocks
Kansas City Southern director Henry Maier buys 3,000 shares »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

RXII

RXi Pharmaceuticals

$0.58

-0.02 (-3.36%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WIN

Windstream

$1.98

0.06 (3.13%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Hot Stocks
Windstream CEO acquires 25,381 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$2.44

-0.22 (-8.27%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRN

Trinity Industries

$28.20

-0.03 (-0.11%)

17:25
08/18/17
08/18
17:25
08/18/17
17:25
Hot Stocks
ValueAct raises stake inTrinity Industries to 11% from 9.8% »

As of this date, ValueAct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTN

Lpath

17:11
08/18/17
08/18
17:11
08/18/17
17:11
Hot Stocks
Breaking Hot Stocks news story on Lpath »

Stonepine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$48.63

0.12 (0.25%)

17:08
08/18/17
08/18
17:08
08/18/17
17:08
Hot Stocks
Progressive CFO sells 50,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$172.57

-0.32 (-0.19%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Thermo Fisher director sells 11,318 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SMBC

Southern Missouri Bancorp

$31.18

-0.05 (-0.16%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Southern Missouri Bancorp and Southern Missouri Bancshares to merge »

Southern Missouri Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:58
08/18/17
08/18
16:58
08/18/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ended advisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says never had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:56
08/18/17
08/18
16:56
08/18/17
16:56
Hot Stocks
Icahn no longer special advisor to President Trump on regulatory reform issues »

Carl Icahn, founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:55
08/18/17
08/18
16:55
08/18/17
16:55
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:49
08/18/17
08/18
16:49
08/18/17
16:49
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$30.38

0.76 (2.57%)

16:48
08/18/17
08/18
16:48
08/18/17
16:48
Hot Stocks
Micron director sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

INSY

Insys Therapeutics

$9.17

-0.11 (-1.19%)

16:42
08/18/17
08/18
16:42
08/18/17
16:42
Hot Stocks
Insys agrees to pay $4.45M to settle opioid marketing suit »

Illinois Attorney General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

16:34
08/18/17
08/18
16:34
08/18/17
16:34
Syndicate
Breaking Syndicate news story on Akari Therapeutics »

Akari Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMBA

Jamba

$9.11

-0.04 (-0.44%)

16:32
08/18/17
08/18
16:32
08/18/17
16:32
Hot Stocks
Jamba receives expected letter from Nasdaq »

Jamba, Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIL

Hill International

$4.50

0.2 (4.65%)

16:31
08/18/17
08/18
16:31
08/18/17
16:31
Hot Stocks
Hill International receives NYSE notice regarding late Form 10-Q filing »

Hill International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$55.65

-0.47 (-0.84%)

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Periodicals
Target ends relationship with food startup Hampton Creek, Bloomberg says »

After an internal review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Options
Preliminary option volume of 23.2M today »

Preliminary option volume…

NBEV

New Age Beverages

$3.51

-0.49 (-12.25%)

16:29
08/18/17
08/18
16:29
08/18/17
16:29
Hot Stocks
New Age Beverages director sells nearly 42,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

, ESV

Ensco

$4.28

0.12 (2.88%)

16:24
08/18/17
08/18
16:24
08/18/17
16:24
Hot Stocks
Atwood Oceanics, Ensco file proxy materials in connection with pending merger »

Ensco (ESV) and Atwood…

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

ESV

Ensco

$4.28

0.12 (2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$83.76

-0.1 (-0.12%)

16:23
08/18/17
08/18
16:23
08/18/17
16:23
Periodicals
Nestle faces potential fraud suit over Poland Spring marketing, WSJ says »

Nestle is facing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.